IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.157
AS - Asia 13.024
EU - Europa 11.103
SA - Sud America 3.185
AF - Africa 347
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 50.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.073
SG - Singapore 4.720
CN - Cina 3.210
RU - Federazione Russa 3.204
IT - Italia 2.879
BR - Brasile 2.497
VN - Vietnam 1.928
GB - Regno Unito 1.406
HK - Hong Kong 920
DE - Germania 825
BD - Bangladesh 727
CA - Canada 719
FR - Francia 499
UA - Ucraina 469
FI - Finlandia 340
IN - India 299
IE - Irlanda 268
SE - Svezia 251
AR - Argentina 247
MX - Messico 245
NL - Olanda 194
TR - Turchia 185
PL - Polonia 183
ID - Indonesia 163
IQ - Iraq 136
ES - Italia 128
ZA - Sudafrica 128
DK - Danimarca 123
EC - Ecuador 122
IL - Israele 118
JP - Giappone 113
PK - Pakistan 101
AT - Austria 84
CO - Colombia 83
UZ - Uzbekistan 61
VE - Venezuela 60
MA - Marocco 58
AE - Emirati Arabi Uniti 51
LT - Lituania 48
PY - Paraguay 47
CL - Cile 45
PE - Perù 36
SA - Arabia Saudita 35
PH - Filippine 33
EG - Egitto 32
KE - Kenya 29
TN - Tunisia 29
CH - Svizzera 27
UY - Uruguay 23
AZ - Azerbaigian 22
DZ - Algeria 21
EU - Europa 21
MY - Malesia 21
BO - Bolivia 20
JO - Giordania 20
BE - Belgio 19
CR - Costa Rica 19
AU - Australia 18
NP - Nepal 18
DO - Repubblica Dominicana 15
RO - Romania 15
HN - Honduras 14
JM - Giamaica 14
KZ - Kazakistan 14
AL - Albania 13
CZ - Repubblica Ceca 13
OM - Oman 13
TW - Taiwan 12
AM - Armenia 10
GT - Guatemala 10
HU - Ungheria 10
IR - Iran 10
PA - Panama 10
TH - Thailandia 10
GR - Grecia 9
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
BB - Barbados 8
KR - Corea 8
KW - Kuwait 8
LB - Libano 8
MC - Monaco 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BY - Bielorussia 7
SN - Senegal 7
BH - Bahrain 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
HR - Croazia 6
LV - Lettonia 6
MD - Moldavia 6
QA - Qatar 6
RS - Serbia 6
SI - Slovenia 6
BA - Bosnia-Erzegovina 5
CI - Costa d'Avorio 5
MK - Macedonia 5
Totale 50.762
Salva come PNG Salva come JPEG
Città #
Dallas 4.536
Singapore 2.480
Ashburn 1.497
San Jose 1.485
Chicago 1.308
Beijing 1.262
Los Angeles 1.074
Hong Kong 867
Ho Chi Minh City 619
Moscow 588
Salt Lake City 554
Southend 540
New York 494
Chandler 443
Buffalo 436
Fairfield 411
Hanoi 376
Houston 341
Woodbridge 331
San Mateo 329
Tampa 313
Wilmington 284
The Dalles 281
Seattle 275
São Paulo 261
Dublin 259
Milan 255
Elk Grove Village 248
Ann Arbor 243
Santa Clara 240
Cambridge 237
Falls Church 232
Lauterbourg 231
Hefei 221
Boardman 209
Helsinki 209
Rome 201
Jacksonville 189
Ottawa 188
Council Bluffs 182
Dearborn 162
Pisa 158
Beauharnois 156
Warsaw 155
Portsmouth 153
Orem 151
Montreal 145
Munich 145
Stevenage 141
Sterling 123
Mexico City 121
Brooklyn 116
Frankfurt am Main 116
Lancaster 116
Dong Ket 115
London 114
Florence 113
Lawrence 106
Tel Aviv 105
Denver 98
Tokyo 98
Poplar 95
Amsterdam 93
Istanbul 91
Phoenix 90
Chennai 87
Miami 87
Atlanta 86
Johannesburg 86
Rio de Janeiro 85
Toronto 85
Stockholm 82
Da Nang 77
Dulles 72
Nuremberg 72
Naples 62
Haiphong 59
Belo Horizonte 57
Detroit 57
Bologna 56
Tashkent 56
Manchester 55
San Diego 54
Lappeenranta 53
Boston 51
Turku 51
Washington 49
Kansas City 48
Brasília 46
Genoa 46
San Francisco 45
Turin 45
Baghdad 44
Biên Hòa 44
Curitiba 43
Querétaro 43
Mumbai 42
Porto Alegre 42
Guangzhou 41
Quito 41
Totale 29.854
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.834
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.697
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.569
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 719
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 691
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 610
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 420
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 389
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 377
A simple echocardiographic score to rule out cardiac amyloidosis 375
The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians 370
A simple echocardiographic score to rule out cardiac amyloidosis 345
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 333
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 319
Adrenergic activation in heart failure: blockade or rebalance? 308
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 305
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 301
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 298
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 297
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 297
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 294
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 290
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 289
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 288
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 288
Screening the health status of people working in a university 285
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 284
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 284
Eligibility for vericiguat in a real‐world, contemporary heart failure population 283
[Ten perspectives for research and innovation in cardiac amyloidosis] 283
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 283
Sex-related differences in chronic heart failure 279
How to take arms against central apneas in heart failure 275
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 272
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 271
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 270
Cardiac light-chain deposition disease relapsing in the transplanted heart 268
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 264
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 263
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 262
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 262
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 262
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 261
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 260
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 260
null 258
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 258
Update sui biomarcatori nello scompenso cardiaco. 257
Valve disease in cardiac amyloidosis: an echocardiographic score 256
Atrial amyloidosis: mechanisms and clinical manifestations 255
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 255
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 254
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 253
null 253
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 252
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 251
RNA-targeting and gene editing therapies for transthyretin amyloidosis 250
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 250
Biomarkers for the diagnosis and management of heart failure: New frontiers 246
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 244
Biomarkers for the diagnosis and management of heart failure 240
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 240
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 238
Role of Imaging in Cardiomyopathies 235
Valvular heart disease in patients with cardiac amyloidosis 235
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 234
Disease features and management of cardiomyopathies in women 233
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 232
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 232
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 228
null 228
null 226
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 226
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 225
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 223
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 223
The search for efficient diagnostic and prognostic biomarkers of heart failure 223
Renin profiling predicts neurohormonal response to sacubitril/valsartan 223
Prognostic value of plasma Renin activity in heart failure. 222
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 222
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 220
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 220
null 218
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 218
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 218
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 218
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 217
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 217
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 217
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 215
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 215
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 214
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 213
Cardiac amyloidosis: Innovations in diagnosis and treatment 211
Tissue Characterization in Cardiac Amyloidosis 211
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 210
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 209
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 208
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 207
Totale 31.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 0 0 311
2021/20221.911 161 295 80 196 74 67 201 333 141 195 36 132
2022/20231.334 109 110 62 140 164 175 36 120 251 30 82 55
2023/20241.331 76 36 239 101 73 120 102 65 51 75 55 338
2024/202513.797 112 134 488 200 420 492 1.186 2.129 814 2.025 3.141 2.656
2025/202628.075 1.478 4.075 3.965 3.855 2.791 1.808 2.690 1.350 1.812 1.912 2.032 307
Totale 51.191